Louvain-la-Neuve, Belgium, September 27, 2016 - IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces today that it has signed a contract with Proton Partners International (PPI) to install a Proteus®ONE* compact proton therapy solution in a private clinic in Abu Dhabi, UAE.

This will be the first ever compact proton therapy solution to be sold and installed in the Middle East region.

The contract, which was previously announced upon the signing of a letter of intent in an IBA press release dated June 28th 2016, covers delivery of the Proteus®ONE equipment, including Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities, making it the compact solution best suited for Adaptive Treatment. The contract also includes a maintenance agreement. The typical end-user price for a Proteus®ONE solution with a maintenance contract is between EUR 35 and 40 million.

This project, the fourth center to be built for PPI, is part of a framework agreement that IBA and Philips signed in September 2014 to advance the diagnosis and treatment of cancer.

Olivier Legrain, Chief Executive Officer of IBA, commented: “Proton Partners International’s partnership with IBA, born from IBA’s longstanding partnership with Philips, not only strengthens our world leading position in proton therapy, but also highlights the preference of IBA as the most experienced and most reliable proton therapy provider in the market with the fastest delivery times. We are excited about our first project in the Middle East, a region that holds tremendous potential for proton therapy.”

Mike Moran, Chief Executive Officer of Proton Partners International Limited, added: "We have been extremely satisfied with our collaboration with IBA and thus it was a natural choice to select IBA for our new project in the Middle East. We are excited about the opportunity to deliver the first proton therapy centre in Abu Dhabi, UAE and we look forward to working with a range of stakeholders to help support the research effort in the wider use of proton beam therapy for the benefit of the patients from all over Middle East region."


About Proteus®ONE
Proteus®ONE is the compact intensity modulated proton therapy (IMPT) solution from IBA. It benefits from the latest technologies developed with renowned clinical institutions. Proteus®ONE is smaller, more affordable, easier to install and to operate. It is ultimately easier to finance, making this advanced radiation therapy modality available to more institutions and patients worldwide. Proteus®ONE makes proton herapy easy.

Rad Oncology Homepage